It is a household services private limited company based in Indore, Madhya Pradesh, India, established in 2012.
2012 | Indore, Madhya Pradesh, India | Under Process Of Striking OffAptosis Lifesciences Private Limited, a under process of striking off private limited company, was established on 05 November 2012 in Indore, Madhya Pradesh, India. Engaging in undifferentiated goods-producing activities of private households for own use within the household services sector, it holds CIN: U22100MP2012PTC029507. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Therazen Lifescience Private Limited, Orenda Medicare Private Limited. It upholds a compliant status. Its leadership includes Shailesh Shah (Director), Umang Shah (Director). Past directors included Savita Nandkishore Managoli, Nandkishor Bapurao Managoli, Minesh Omkar Patil. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at G-14, Mig Colony, R.S.S. Nagar, Indore, Madhya Pradesh, 452010.
U22100MP2012PTC029507
029507
05 November 2012
₹0.10 M
₹0.10 M
Roc Gwalior
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Aptosis Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Shah | Director | 05 Nov 2012 | Current |
| Umang Shah | Director | 05 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 10 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aptosis Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Aptosis Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aptosis Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aptosis Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aptosis Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aptosis Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Aptosis Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior. was recorded as a recent event.
Shailesh Shah was appointed as a Director was appointed as a Director on 05 Nov 2012 & has been associated with this company since 13 years 25 days . was recorded as a recent event.
Progress on Umang Shah was appointed as a Director was appointed as a Director on 05 Nov 2012 & has been associated with this company since 13 years 25 days . was documented.
The activity Aptosis Lifesciences Private Limited was registered on 05 Nov 2012 with Roc Gwalior & aged 13 years 25 days as per MCA records. was completed.
The CIN of Aptosis Lifesciences Private Limited is U22100MP2012PTC029507.
Aptosis Lifesciences Private Limited is headquartered at G-14, Mig Colony, R.S.S. Nagar, Indore, Madhya Pradesh, 452010.
Aptosis Lifesciences Private Limited was incorporated on 05 November 2012.
The current directors of Aptosis Lifesciences Private Limited are
The primary industry of Aptosis Lifesciences Private Limited is Household Services.
Aptosis Lifesciences Private Limited is unlisted.
The authorized capital of Aptosis Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aptosis Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX